JP2004500110A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004500110A5 JP2004500110A5 JP2001570286A JP2001570286A JP2004500110A5 JP 2004500110 A5 JP2004500110 A5 JP 2004500110A5 JP 2001570286 A JP2001570286 A JP 2001570286A JP 2001570286 A JP2001570286 A JP 2001570286A JP 2004500110 A5 JP2004500110 A5 JP 2004500110A5
- Authority
- JP
- Japan
- Prior art keywords
- hsa
- cells
- polypeptide
- human
- mice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19281400P | 2000-03-29 | 2000-03-29 | |
| PCT/US2001/040390 WO2001072325A1 (en) | 2000-03-29 | 2001-03-29 | Methods of blocking tissue destruction by autoreactive t cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004500110A JP2004500110A (ja) | 2004-01-08 |
| JP2004500110A5 true JP2004500110A5 (https=) | 2008-05-15 |
Family
ID=22711138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001570286A Pending JP2004500110A (ja) | 2000-03-29 | 2001-03-29 | 自己反応性ｔ細胞による組織破壊をブロックする方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1267909B1 (https=) |
| JP (1) | JP2004500110A (https=) |
| AT (1) | ATE475428T1 (https=) |
| AU (2) | AU2001259792B2 (https=) |
| CA (1) | CA2404340C (https=) |
| DE (1) | DE60142684D1 (https=) |
| DK (1) | DK1267909T3 (https=) |
| WO (1) | WO2001072325A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030106084A1 (en) | 2000-03-29 | 2003-06-05 | Yang Liu | Methods of blocking tissue destruction by autoreactive T cells |
| DK2563385T3 (da) * | 2010-04-28 | 2017-11-06 | Oncoimmune Inc | Fremgangsmåder til anvendelse af opløselig cd24 til behandling af reumatoid artritis |
| CN104507537A (zh) * | 2012-07-13 | 2015-04-08 | 宾夕法尼亚大学董事会 | 用于调节car t细胞的组合物和方法 |
| GB201300684D0 (en) | 2013-01-15 | 2013-02-27 | Apitope Int Nv | Peptide |
| TWI750110B (zh) | 2014-07-21 | 2021-12-21 | 瑞士商諾華公司 | 使用人類化抗-ｂｃｍａ嵌合抗原受體治療癌症 |
| KR20170037625A (ko) | 2014-07-21 | 2017-04-04 | 노파르티스 아게 | Cll-1 키메라 항원 수용체를 사용한 암의 치료 |
| CN107207597A (zh) * | 2014-11-06 | 2017-09-26 | 儿研所儿童医学中心 | 用于癌症和自身免疫疾病的免疫疗法 |
| BR112017022394A2 (pt) * | 2015-05-07 | 2018-07-17 | Oncoimmune Inc | uso de cd24 para diminuir níveis de colesterol das lipoproteínas de baixa densidade |
| WO2017025963A1 (en) * | 2015-08-10 | 2017-02-16 | The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center | Methods and pharmaceutical compositions for improving wound healing using cd24 |
| KR20180120145A (ko) * | 2016-02-02 | 2018-11-05 | 온코이뮨, 아이앤씨. | 렙틴-결핍 병태를 치료하기 위한 cd24 단백질의 용도 |
| WO2018165204A1 (en) * | 2017-03-07 | 2018-09-13 | Oncoimmune, Inc. | Methods of use of soluble cd24 for treating systemic lupus erythematosus |
| US20200181235A1 (en) * | 2017-05-15 | 2020-06-11 | Oncoimmune, Inc. | Methods of use of soluble cd24 for neuroprotection and remyelination |
| CA3100724A1 (en) | 2018-06-13 | 2019-12-19 | Novartis Ag | B-cell maturation antigen protein (bcma) chimeric antigen receptors and uses thereof |
-
2001
- 2001-03-29 EP EP01933358A patent/EP1267909B1/en not_active Expired - Lifetime
- 2001-03-29 AU AU2001259792A patent/AU2001259792B2/en not_active Ceased
- 2001-03-29 DE DE60142684T patent/DE60142684D1/de not_active Expired - Lifetime
- 2001-03-29 DK DK01933358.2T patent/DK1267909T3/da active
- 2001-03-29 JP JP2001570286A patent/JP2004500110A/ja active Pending
- 2001-03-29 AU AU5979201A patent/AU5979201A/xx active Pending
- 2001-03-29 WO PCT/US2001/040390 patent/WO2001072325A1/en not_active Ceased
- 2001-03-29 AT AT01933358T patent/ATE475428T1/de not_active IP Right Cessation
- 2001-03-29 CA CA2404340A patent/CA2404340C/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12319741B2 (en) | Human monoclonal antibody human CD134 (OX40) and methods of making and using same | |
| AU2018209012B2 (en) | BCMA-targeting antibody and use thereof | |
| US6737057B1 (en) | Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors | |
| EP1292621B1 (en) | Compositions for treating autoimmune disease | |
| HUE029789T2 (en) | Trimer OX40 Immunoglobulin Fusion Protein and Methods of Application | |
| JPH09509826A (ja) | 活性化ｃｄ４▲上＋▼ｔ細胞の表層上のレセプターに対するリガンド（ａｃｔ−４−ｌ） | |
| JP2002514895A (ja) | ブタ細胞相互作用タンパク質 | |
| JP2009240311A (ja) | 活性化されたｔ細胞の表面上のレセプタ：ａｃｔ−４ | |
| TW200823235A (en) | Prophylactic and therapeutic agent for cancers | |
| KR102296416B1 (ko) | 항-세라마이드 항체 | |
| JP2012513761A (ja) | 初期の眼内リンパ腫の治療に対する抗ｃｄ２０抗体の使用方法 | |
| CA2404340C (en) | Methods of blocking tissue destruction by autoreactive t cells | |
| US20090280132A1 (en) | Coupling of peripheral tolerance to endogenous il-10 promotes effective modulation of t cells and ameliorates autoimmune disease | |
| JP2004500110A5 (https=) | ||
| KR101985863B1 (ko) | ADCC 향상을 위한 항체 Fc 변이체 | |
| US20030106084A1 (en) | Methods of blocking tissue destruction by autoreactive T cells | |
| AU2001259792A1 (en) | Methods of blocking tissue destruction by autoreactive T cells | |
| US20070218053A1 (en) | Coupling of peripheral tolerance to endogenous il-10 promotes effective modulation of t cells and ameliorates autoimmune disease | |
| US20030095966A1 (en) | Method of blocking tissue destruction by autoreactive T cells | |
| US20040210037A1 (en) | Targeted MHC class I alpha3 vaccine delivery systems | |
| WO2007101254A2 (en) | Compositions and methods for the treatment of immune system disorders | |
| RU2799655C2 (ru) | Антитело, нацеленное на всма, и его применение |